BR0012627A - Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial - Google Patents

Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial

Info

Publication number
BR0012627A
BR0012627A BR0012627-6A BR0012627A BR0012627A BR 0012627 A BR0012627 A BR 0012627A BR 0012627 A BR0012627 A BR 0012627A BR 0012627 A BR0012627 A BR 0012627A
Authority
BR
Brazil
Prior art keywords
flow filtration
tangential flow
dna
purify
cells
Prior art date
Application number
BR0012627-6A
Other languages
English (en)
Inventor
Marjorie E Winkler
Michelle D Butler
Darien L Cohen
David Kahn
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR0012627A publication Critical patent/BR0012627A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/894Manufacture, treatment, or detection of nanostructure having step or means utilizing biological growth
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/895Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898Enzymatic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908Mechanical repair performed/surgical
    • Y10S977/91Strengthening cell or tissue
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908Mechanical repair performed/surgical
    • Y10S977/912Cancer cell repair
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914Protein engineering
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO PARA PURIFICAR O DNA DE PLASMìDEO DE CéLULAS PROCARIóTICAS MEDIANTE O EMPREGO DE FILTRAçãO DE FLUXO TANGENCIAL". é descrito um processo para a purificação de DNA de plasmídeo de células procarióticas que os contêm. Esse processo compreende as etapas de: (a) digestão das células; (b) incubação das células durante aproximadamente 4 a 24 horas para efetuar a sua lise e solubilização, sem afetar a digestão enzimática do RNA; (c) remoção dos contaminantes de lisado das células, para se obter uma solução de DNA de plasmídeo; (d) filtração da solução através de um dispositivo de filtração de fluxo tangencial para se obter um material retido contendo o DNA de plasmídeo; e (e) coleta do material retido.
BR0012627-6A 1999-07-23 2000-07-21 Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial BR0012627A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14531699P 1999-07-23 1999-07-23
US16520699P 1999-11-12 1999-11-12
PCT/US2000/019963 WO2001007599A1 (en) 1999-07-23 2000-07-21 Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration

Publications (1)

Publication Number Publication Date
BR0012627A true BR0012627A (pt) 2002-04-09

Family

ID=26842848

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012627-6A BR0012627A (pt) 1999-07-23 2000-07-21 Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial

Country Status (18)

Country Link
US (1) US6313285B1 (pt)
EP (1) EP1200578B1 (pt)
JP (1) JP2003505077A (pt)
KR (1) KR100669305B1 (pt)
CN (1) CN1378592A (pt)
AT (1) ATE264386T1 (pt)
BR (1) BR0012627A (pt)
CA (1) CA2378944A1 (pt)
DE (1) DE60009912T2 (pt)
DK (1) DK1200578T3 (pt)
ES (1) ES2218185T3 (pt)
HK (1) HK1048829A1 (pt)
HU (1) HUP0202295A3 (pt)
IL (1) IL147644A0 (pt)
NZ (1) NZ516641A (pt)
PL (1) PL364816A1 (pt)
PT (1) PT1200578E (pt)
WO (1) WO2001007599A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602414B2 (en) * 2000-03-30 2003-08-05 Formulations Pro Molecule separation device and method combining multiple filtration media
AU2001294890A1 (en) * 2000-09-25 2002-04-02 Board Of Regents, The University Of Texas System Pei: dna vector formulations for in vitro and in vivo gene delivery
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
GB0028361D0 (en) * 2000-11-21 2001-01-03 Glaxo Group Ltd Method of separating extra chromosomal dna from other cellular components
JP3547715B2 (ja) * 2001-03-06 2004-07-28 榮 新垣 ベクター精製用装置及び方法
GB0107634D0 (en) * 2001-03-27 2001-05-16 Fermentas Ab Nucleic acid purification
WO2003064605A2 (en) 2002-01-28 2003-08-07 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
EP1554398A4 (en) 2002-09-13 2005-12-14 Valentis Inc DEVICE AND METHOD FOR THE CLEANING OF NUCLEAR SULFUR IN THE PREPARATIVE SCALE
US8501402B2 (en) 2003-03-24 2013-08-06 Boehringer Ingelheim Rcv Gmbh & Co Kg Methods and devices for producing biomolecules
CN1283792C (zh) 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
SE0400490D0 (sv) 2004-02-26 2004-02-26 Amersham Biosciences Ab Plasmid purification
CA2595594C (en) 2005-01-31 2012-05-01 Merck & Co., Inc. Upstream and a downstream purification process for large scale production of plasmid dna
US20080102493A1 (en) * 2006-06-29 2008-05-01 Millipore Corporation Isolation of RNA and DNA from a biological sample
US7964350B1 (en) * 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
WO2008150826A1 (en) * 2007-05-31 2008-12-11 Ge Healthcare Uk Limited Modified spin column for simple and rapid plasmid dna extraction
EP2088196A1 (en) 2008-02-08 2009-08-12 Boehringer Ingelheim RCV GmbH & Co KG Methods and devices for producing biomolecules
WO2009129524A2 (en) * 2008-04-18 2009-10-22 The General Hospital Corporation High-throughput plasmid dna preparation
TWI469992B (zh) * 2008-08-28 2015-01-21 Baxter Int 濃縮剪切靈敏生物聚合物的方法
US8211637B2 (en) * 2008-12-19 2012-07-03 Life Technologies Corporation Proteinase K inhibitors, methods and compositions therefor
PL3338765T3 (pl) 2009-12-01 2019-06-28 Translate Bio, Inc. Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych
KR101551298B1 (ko) 2011-04-01 2015-09-08 이엠디 밀리포어 코포레이션 나노섬유 함유 복합재료 구조
CN111671918A (zh) 2011-06-08 2020-09-18 川斯勒佰尔公司 Mrna递送的脂质纳米颗粒组合物和方法
US20150267192A1 (en) 2012-06-08 2015-09-24 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
ES2708561T3 (es) 2013-03-14 2019-04-10 Translate Bio Inc Métodos para la purificación de ARN mensajero
AU2014236305B2 (en) 2013-03-14 2019-01-17 Ethris Gmbh CFTR mRNA compositions and related methods and uses
CN103525866A (zh) * 2013-03-22 2014-01-22 人福医药集团股份公司 制备质粒的方法
CN106413811A (zh) 2013-10-22 2017-02-15 夏尔人类遗传性治疗公司 精氨基琥珀酸合成酶缺乏症的mrna疗法
JP6506749B2 (ja) 2013-10-22 2019-04-24 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド フェニルケトン尿症のためのmRNA療法
DK178664B1 (en) * 2013-10-25 2016-10-24 Amphi Consult V Martin Hesselsøe Aps A system and a method for concentrating traces of tissue from aquatic organisms in a water sample and use thereof
EP3085769B1 (en) * 2013-12-18 2020-04-15 Asahi Kasei Kabushiki Kaisha Method for detecting coliform bacteria contained in milk
ES2750661T3 (es) 2014-04-25 2020-03-26 Translate Bio Inc Métodos para la purificación de ARN mensajero
KR20210115050A (ko) 2014-06-26 2021-09-24 이엠디 밀리포어 코포레이션 개선된 먼지 포집 능력을 갖는 필터 구조
KR20170113638A (ko) * 2015-04-17 2017-10-12 이엠디 밀리포어 코포레이션 접선방향 유동 여과 모드에서 작동되는 나노섬유 한외여과막을 사용하여 샘플에서 목적하는 생물학적 물질을 정제하는 방법
WO2016180430A1 (en) 2015-05-08 2016-11-17 Curevac Ag Method for producing rna
EP4108769B1 (en) 2015-05-29 2023-08-30 CureVac Manufacturing GmbH A method for producing and purifying rna, comprising at least one step of tangential flow filtration
WO2018157154A2 (en) 2017-02-27 2018-08-30 Translate Bio, Inc. Novel codon-optimized cftr mrna
EP3624824B1 (en) 2017-05-16 2024-07-10 Translate Bio, Inc. Codon-optimized mrna encoding cftr for use in treating cystic fibrosis
CN118421617A (zh) 2018-08-24 2024-08-02 川斯勒佰尔公司 用于纯化信使rna的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128669A1 (de) * 1981-07-20 1983-02-03 Hoechst Ag, 6000 Frankfurt "plasmid p svh 1 und seine verwendung"
GB8600582D0 (en) 1986-01-10 1986-02-19 Ca Minister Nat Defence Purifying biological materials
AU605901B2 (en) 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
CA2192342A1 (en) 1994-07-15 1996-02-01 Ann L. Lee A method for large scale plasmid purification
US6011148A (en) 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
US5707812A (en) 1996-08-06 1998-01-13 Vical Incorporated Purification of plasmid DNA during column chromatography
EP0853123A1 (de) * 1997-01-10 1998-07-15 Roche Diagnostics GmbH Reinigung von DNA durch Cross-Flow-Filtration
CA2830694C (en) * 1997-09-05 2018-02-27 Genzyme Corporation Methods for generating high titer helper-free preparations of recombinant aav vectors
SE9703532D0 (sv) 1997-09-30 1997-09-30 Pharmacia Biotech Ab A process for the purification of plasmid DNA
WO1999063076A1 (en) 1998-06-01 1999-12-09 The Immune Response Corporation Novel method of large scale plasmid purification
US6268492B1 (en) 1998-08-10 2001-07-31 Chiron Corporation Methods for purifying non-chromosomal nucleic acid molecules from cells

Also Published As

Publication number Publication date
NZ516641A (en) 2003-07-25
DK1200578T3 (da) 2004-07-26
ES2218185T3 (es) 2004-11-16
HK1048829A1 (zh) 2003-04-17
EP1200578B1 (en) 2004-04-14
KR20020019123A (ko) 2002-03-09
PT1200578E (pt) 2004-08-31
EP1200578A1 (en) 2002-05-02
HUP0202295A3 (en) 2005-01-28
DE60009912D1 (de) 2004-05-19
JP2003505077A (ja) 2003-02-12
IL147644A0 (en) 2002-08-14
ATE264386T1 (de) 2004-04-15
KR100669305B1 (ko) 2007-01-17
PL364816A1 (en) 2004-12-13
DE60009912T2 (de) 2005-04-14
CA2378944A1 (en) 2001-02-01
HUP0202295A2 (en) 2002-10-28
WO2001007599A1 (en) 2001-02-01
CN1378592A (zh) 2002-11-06
US6313285B1 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
BR0012627A (pt) Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial
BR9710030A (pt) Processo de produção de adenovírus recombinantes processo de purificação de adenovírus recombinantes a partir de um meio biológico preparação viral purificada composição farmacêutica e utilização de iodixanol-5,5'-[(2-Hidroxipropil-1,3-Propanottl)-Bis[N,N'-Bis(2,3-Didroxipropil-2,4,6-Triodo-1,3-Benzenocarboxamida]
DK0923592T3 (da) Fremgangsmåder til rensning af nukleinsyrer
BR0010496A (pt) Regulação da expressão genica viral
BR9916654A (pt) Processo de separação de partìculas virais a partir de um meio biológico e de quantificação de adenovìrus e utilização de um suporte de cromatografia
CA2231971A1 (en) Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
BR9810964A (pt) Processo e dispositivo de purificação de águas servidas, compreendendo um tratamento adicional das lamas por ozonização
BR9904955A (pt) Dna bactéria pertencendo ao gênero escherichia, e, processo para produzir um aminoácido.
EP1394259A3 (en) Recombinant infectious non-segmented negative strand RNA virus
HUP9903829A1 (hu) RNS-vírusok fertőző klónjai,belőlük kifejlesztett vakcinák és diagnosztikai eljárások
DE68901411D1 (de) Integrierte vorrichtung zur biospezifischen reinigung einer zellen enthaltenden fluessigkeit.
BR9607640A (pt) Processo para remover impurezas de argilas de caulim
BR9609972A (pt) Processo para condicionar argilas de caulim antes da remoção de impurezas
AU2008331435B2 (en) Bisulphite treatment of RNA
CA2250890A1 (en) Process for the biological purification of waste water
BR9801085A (pt) Processo para a preparação de moenomicina a.
CN1966709B (zh) 一种重组新疆家蚕抗菌肽制备方法及其获得的新疆家蚕抗菌肽与应用
BR0001342A (pt) Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
ES2139418T3 (es) Procedimiento para la purificacion de dialdehido o-ftalico.
BRPI0411888A (pt) processo de limpar filtro elétrico e filtro elétrico
HUP0101324A2 (hu) Szénszálas szűrők
BR9810896A (pt) Processo de preparação de derivados aminas de alquiloxifuranona, compostos provenientes desse processo e utilização desses compostos
BR0308736A (pt) Células de pulmão de rato cotton para cultura de vìrus
CN1673116A (zh) 一种污水净化剂的制备方法

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.